Incannex Healthcare Halted, News Pending
On Friday, HSBC analyst Sorabh Daga upgraded Keurig Dr Pepper (NASDAQ:KDP) shares from Hold to Buy and increased the price target to $42.00, up from the previous target of $36.00. This adjustment follows Keurig Dr Pepper’s announcement of first-quarter net sales growth of 6% and a comparable earnings per share (EPS) increase of 10%, reported on April 24. According to InvestingPro data, the company maintains impressive gross profit margins of 55.35% and has consistently raised its dividend for 4 consecutive years.
Keurig Dr Pepper’s performance has allowed the company to maintain its full-year guidance, which anticipates mid-single-digit revenue growth and high-single-digit EPS growth. This is particularly noteworthy as many other companies are revising their forecasts downward. InvestingPro analysis suggests the company is currently trading below its Fair Value, with additional metrics and insights available in the comprehensive Pro Research Report, one of 1,400+ detailed company analyses.
Daga’s analysis has led to an updated projection for a stronger-than-expected first-quarter result. Adjustments were made to growth forecasts and the estimated EPS for the year 2025, which now stands at $2.06, up from the previous estimate of $2.03. This revision is attributed to a robust beverage business and sequential improvements in the coffee segment.
The new price target of $42 implies a 22% upside from the current level. According to HSBC’s report, Keurig Dr Pepper is currently trading at 16.6 times its 1-year forward price-to-earnings ratio, which is 13% below its 5-year average of 18.9 times. The company’s recent financial outcomes and the analyst’s adjusted expectations underscore the decision to upgrade the stock rating and raise the price target.
In other recent news, Keurig Dr Pepper Inc. reported its first-quarter 2025 earnings, surpassing expectations with an earnings per share (EPS) of $0.42, compared to the forecasted $0.38. The company also exceeded revenue projections, reporting $3.64 billion against an anticipated $3.56 billion. Despite a 3.7% decline in net sales for the US Coffee segment, the US Refreshment Beverages segment showed robust performance with an 11% increase in net sales. The company’s operating income grew by 3.9%, although the gross margin contracted by 170 basis points. Keurig Dr Pepper maintained its guidance for mid-single-digit net sales growth and high single-digit EPS growth for the year. Meanwhile, the company announced the appointment of two new independent directors to its Board of Directors, indicating a strategic focus on governance. Additionally, Keurig Dr Pepper is advancing initiatives such as the development of the Keurig Alta system and plastic-free K-Rounds pods.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.